Location History:
- Nedham, MA (US) (2013)
- Needham, MA (US) (2013 - 2024)
Company Filing History:
22 out of 36 
2 out of 34 
1 out of 1 Years Active: 2013-2024
Title: Innovations of Mao Yin: A Pioneer in Antibody-Drug Conjugates
Introduction
Mao Yin, based in Needham, MA, has made significant contributions to the field of biochemistry and oncology through his innovative work in antibody-drug conjugates. With an impressive portfolio of 25 patents, Yin has positioned himself as a leading inventor in therapeutic applications that leverage bioconjugation techniques.
Latest Patents
Yin’s latest patents showcase his cutting-edge research. One of his notable inventions involves "Peptide-containing linkers for antibody-drug conjugates." This patent discusses the use of peptide-containing scaffolds to conjugate with targeting moieties, such as antibodies, to produce effective therapeutics and diagnostics. Another significant patent is focused on "Pyrrolobenzodiazepine antibody conjugates," which revolves around the development of antibody-drug conjugates that incorporate pyrrolo[2, 1-c][1, 4]benzodiazepine (PBD) drug moieties. This innovation also pertains to methods of utilizing these conjugates for therapeutic and diagnostic purposes.
Career Highlights
Throughout his career, Yin has been associated with prominent companies in the biotech sector, including Mersana Therapeutics, Inc. and Asana Biosciences, LLC. His roles in these organizations have contributed significantly to the development and commercialization of novel therapeutic agents that advance patient care.
Collaborations
Yin’s work has been enriched by collaborations with talented professionals in the field. Notable coworkers include Aleksandr V. Yurkovetskiy and Timothy B. Lowinger. Together, they have worked on groundbreaking research that pushes the boundaries of existing therapeutic methods.
Conclusion
Mao Yin continues to be a driving force in the realm of antibody-drug conjugates, with his innovative patents promising to impact therapies and diagnostics profoundly. With a blend of collaboration and ingenuity, Yin is paving the way for future advancements in medical science. His body of work not only reflects his inventive spirit but also highlights the potential for new therapeutic strategies in oncology.